Willis Kent A, Weems Mark F
Division of Neonatology and Le Bonheur Children's Hospital, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
Congenit Heart Dis. 2019 Jan;14(1):27-32. doi: 10.1111/chd.12691. Epub 2018 Oct 20.
Patent ductus arteriosus (PDA) is prevalent in premature newborns and has been linked to the development of bronchopulmonary dysplasia (BPD), a serious pulmonary complication of premature birth. Although a causal relationship has not been proven, the link is greatest among infants born at lower gestational age who are treated with mechanical ventilation in the presence of a large ductal shunt. Despite strong association in epidemiological studies, treatment of a patent ductus arteriosus has not been shown to prevent BPD, and some therapies may increase the risk of BPD. We describe preclinical and clinical data demonstrating the association of a PDA with BPD, highlight the effects of surgical and pharmacological treatment, and explore the implications of recent clinical trials for the management of PDA in the premature newborn.
动脉导管未闭(PDA)在早产儿中很常见,并且与支气管肺发育不良(BPD)的发生有关,BPD是早产的一种严重肺部并发症。尽管因果关系尚未得到证实,但在胎龄较小、存在较大导管分流且接受机械通气治疗的婴儿中,这种关联最为明显。尽管在流行病学研究中有很强的相关性,但动脉导管未闭的治疗尚未被证明可预防BPD,而且一些治疗方法可能会增加BPD的风险。我们描述了临床前和临床数据,证明了PDA与BPD之间的关联,强调了手术和药物治疗的效果,并探讨了近期临床试验对早产儿PDA管理的影响。